Position in BBIO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$21,083,973
-$5,002,788 QoQ
Shares Held
283,921
-16.8% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $437,724,004 across 106 Biotechnology names. BBIO ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
827,454 | $22,920,475 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
135,460 | $22,895,449 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
928,568 | $21,691,348 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
363,984 | $21,151,110 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
This page
|
283,921 | $21,083,973 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
264,200 | $15,363,230 | |
| 7 | MRNA |
Moderna, Inc.
|
237,418 | $12,060,834 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
563,999 | $11,031,820 |
All Filings in BBIO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,083,973 | 283,921 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $26,086,761 | 341,048 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,965,984 | 114,863 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,796,034 | 64,753 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $647,584 | 23,600 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,473,940 | 136,447 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,414,629 | 55,848 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $2,764,433 | 89,406 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,535,443 | 87,576 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,728,922 | 65,564 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $686,004 | 39,884 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $701,566 | 42,314 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $558,698 | 73,320 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $348,944 | 38,430 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $406,812 | 40,080 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||